|Articles|September 1, 1999

September 1999
Volume 5
Issue 9

The Changing Healthcare Market: Outlook for the Future of Cardiovascular Disease Treatment - Part II

Author(s)Edmund R. Becker, PhD, Douglas C. Morris, MD, Steven D. Culler, PhD

Download PDF: The Changing Healthcare Market: Outlook for the Future of Cardiovascular Disease Treatment - Part II

Articles in this issue

over 26 years ago

Article

Was the Decreasing Trend in Hospital Mortality from Heart Failure Attributable to Improved Hospital Care? The Oregon Experience, 1991-1995

over 26 years ago

Article

The Changing Healthcare Market and How It Has Influenced the Treatment of Cardiovascular Disease - Part I

over 26 years ago

Article

Selective Contracting and Patient Outcomes: A Case Study of Formulary Restrictions for Selective Serotonin Reuptake Inhibitor Antidepressants

over 26 years ago

Article

Is a Third-Trimester Antibody Screen in Rh+ Women Necessary?

over 26 years ago

Article

Patient Factors Related to the Odds of Receiving Prevention Services in Veterans Health Administration Medical Centers

over 26 years ago

Article

Innovative Healthcare for Chronically Ill Older Persons: Results of a National Survey

over 26 years ago

Article

Office-Based Surgery and Cost Avoidance in an Obstetrics and Gynecology Residency Program

over 26 years ago

Article

Drug Therapy of Allergic Rhinitis

over 26 years ago

Article

Rethinking Formulary Strategy: Management and Measurement Considerations

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

A Health Economic Evaluation of Digital Digestive Care Management

ByMartha Shepherd, DO, MPH,Pen-Che Ho, MS,David Hines, BA,Jon Harris-Shapiro, BA,Dena Bravata, MD, MS,Christopher M. Whaley, PhD,K. Davina Frick, PhD,Emmanuel F. Drabo, PhD,Ron Z. Goetzel, PhD

January 21st 2026

Empowering Children and Parents Through Technology: Opportunities, Challenges, and Future Directions

ByShamsi Atefeh, PhD

January 15th 2026

Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data

ByMohamed M. Ali, MS,Scott Lunos, MS,Zachary Henderson, BSB,Michele Allen, MD, MS,Patricia Adam, MD, MSPH,Genevieve B. Melton, MD, PhD,Rubina Rizvi, MD, PhD

January 12th 2026

Subjective and Objective Impacts of Ambulatory AI Scribes

ByJulia Adler-Milstein, PhD,Orianna DeMasi, PhD,Hossein Soleimani, PhD,Sarah Beck, MDiv,Maria E. Byron, MD,Aris Oates, MD,Robert Thombley, BS,Jinoos Yazdany, MD, MPH,Sara G. Murray, MD, MAS

January 8th 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

The Changing Healthcare Market: Outlook for the Future of Cardiovascular Disease Treatment - Part II

Articles in this issue

Newsletter

Related Content

Specialty and Operator Status Influence Electronic Health Record Use Variation

A Health Economic Evaluation of Digital Digestive Care Management

Empowering Children and Parents Through Technology: Opportunities, Challenges, and Future Directions

Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data

Subjective and Objective Impacts of Ambulatory AI Scribes

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

Congress Unveils Massive Funding Bill to Avert Shutdown

ctDNA Positivity Associated With Worse Survival, Higher Recurrence Risk in Patients With NSCLC

Novel CLL Therapies Prompt New Treatment Considerations

Early Data Show Feasibility of in Vivo CAR T Therapy in Multiple Myeloma

Health Insurance CEOs Questioned by House Committee About Rising Costs in Health Care